| Name | Title | Contact Details |
|---|
Samaritan Regional Health System is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Samaritan Regional Health System is based in Ashland, OH. You can find more information on Samaritan Regional Health System at www.samaritanhospital.org
Improving the self-esteem of the world. Thats the lofty goal of Self Esteem Brands, the parent company of Anytime Fitness (the worlds #1 Top Global franchise), Waxing The City, another award-winning franchise poised for rapid expansion, and Basecamp Fitness. Self Esteem Brands is also the parent company to affiliates Provision Security Solutions, Healthy Contributions, PumpOne and Franchise Real Estate. With the vision of improving the self-esteem of the world at its core, Self Esteem Brands seeks to enrich the lives of all of those who interact with our companies in nearly 30 countries on five continents worldwide. That includes our consumers, vendors, employees, franchisees and the surrounding communities where more than 3,000 of our independently owned and operated franchises are located. Additionally, Self Esteem Brands is actively seeking other innovative business concepts to partner with and franchise.
LIFE Corporation is a Milwaukee, WI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Alivation puts you and your family`s health and well-being first. We do this by investing in the latest medical advancements and meticulously staffing the foremost experts in our industry. From basic behavioral health and family health services to in-depth treatments via transcranial magnetic stimulation therapy (TMS) and brain network monitoring, Alivation`s world-class facility and personal approach to your care is second to none. With a full-service pharmacy and research team on-site, Alivation is the only integrated healthcare clinic in the area that`s large enough to provide a high standard of unique care while being small enough to know our patients on a personal level.
Ovid Therapeutics is a biopharmaceutical company focused exclusively on developing impactful medicines for patients and families living with rare neurological disorders. Ovid`s drug candidate, OV101, is currently in development for the treatment of symptoms of Angelman syndrome and Fragile X syndrome. Ovid is also developing OV935 in collaboration with Takeda Pharmaceutical Company Limited for the treatment of rare epileptic encephalopathies. Ovid has initiated the Phase 2 STARS trial of OV101 in adults with Angelman syndrome and a Phase 1 trial in adolescents with Angelman and Fragile X syndrome to identify doses suitable for younger patients.